Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Concomitant Radiochemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00950417
What this trial is testing

Nimotuzumab in Combination With Chemoradiation for Esophageal Cancer

Who this might be right for
Advanced Esophageal
Biotech Pharmaceutical Co., Ltd. 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT05193617
What this trial is testing

Penpulimab Combined With GP ± Anlotinib as Neoadjuvant Therapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 104
Testing effectiveness (Phase 2)Study completedNCT01102231
What this trial is testing

Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Stage III Non-small Cell Lung Cancer
Intergroupe Francophone de Cancerologie Thoracique 106
Large-scale testing (Phase 3)Looking for participantsNCT04437329
What this trial is testing

Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Affiliated Cancer Hospital & Institute of Guangzhou Medical University 352
Large-scale testing (Phase 3)Active Not RecruitingNCT03306121
What this trial is testing

TPF+CCRT vs.CCRT+PF in High Risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 322
Testing effectiveness (Phase 2)Ended earlyNCT04418648
What this trial is testing

Study of Toripalimab for Limited-Stage Small Cell Lung Cancer Following Concurrent Chemoradiotherapy

Who this might be right for
Small Cell Lung Cancer Limited Stage
Sun Yat-sen University 170
Testing effectiveness (Phase 2)Looking for participantsNCT06730308
What this trial is testing

Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma

Who this might be right for
Thymoma
Sun Yat-sen University 45
Testing effectiveness (Phase 2)Ended earlyNCT01230476
What this trial is testing

Induction and Concurrent Chemoradiotherapy With Cetuximab for Patients With Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
University of Malaya 3
Not applicableLooking for participantsNCT07489391
What this trial is testing

Concomitant Use of Radiotherapy and Integrated Exercise - Lung Cancer

Who this might be right for
Non Small Cell Lung CancerRadiation Therapy PatientStage II/III
University of Deusto 10
Testing effectiveness (Phase 2)Looking for participantsNCT07162506
What this trial is testing

DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT04910347
What this trial is testing

Consolidation Nivolumab After Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Locally Advanced Nasopharyngeal Carcinoma
Yonsei University 57
Testing effectiveness (Phase 2)Study completedNCT01590017
What this trial is testing

Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer

Who this might be right for
Cervical CancerAcquired Immunodeficiency Syndrome
AIDS Malignancy Consortium 41
Not applicableActive Not RecruitingNCT03979924
What this trial is testing

Mouth Opening, Prevention, Education, Nutrition (OPEN)

Who this might be right for
TrismusHead and Neck Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 175
Testing effectiveness (Phase 2)Looking for participantsNCT06093061
What this trial is testing

Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
National Cancer Centre, Singapore 53
Testing effectiveness (Phase 2)UnknownNCT05177497
What this trial is testing

SHR-1701 for Consolidation Therapy After Concurrent Chemoradiotherapy in Inoperable Stage III NSCLC

Who this might be right for
NSCLC, Stage III
Shanghai Chest Hospital 19
Not applicableStudy completedNCT05292027
What this trial is testing

Neoadjuvant Chemotherapy and Low-dose Radiotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sichuan Cancer Hospital and Research Institute 84
Early research (Phase 1)Study completedNCT00724386
What this trial is testing

Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast Cancer

Who this might be right for
Breast Cancer
University of Chicago 26
Testing effectiveness (Phase 2)Study completedNCT00468169
What this trial is testing

Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University of Chicago 110
Testing effectiveness (Phase 2)Study completedNCT06139419
What this trial is testing

The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 114
Not applicableNot Yet RecruitingNCT06882473
What this trial is testing

A Clinical Study of Pelvic Concurrent Chemoradiotherapy Combined with CT-guided Intracavitary Brachytherapy with Adaptive Simultaneous Dose Escalation for Locally Advanced Cervical Cancer

Who this might be right for
Locally Advanced Cervical Cancer
Peking University Third Hospital 20
Next Page